Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/1998
10/15/1998WO1998045314A1 Composition and method for treatment of cmv infections
10/15/1998WO1998044955A1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof
10/15/1998WO1998044954A1 Metal ion transporter and uses therefor
10/15/1998WO1998044953A1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
10/15/1998WO1998044938A1 Modified proteins which bind extracellular matrix components
10/15/1998WO1998044909A1 Improved methods of delivery using cationic lipids and helper lipids
10/15/1998WO1998044788A2 Animal model for evaluation of vaccines
10/15/1998WO1998035693A3 Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease
10/15/1998WO1998030589A3 Secreted proteins and polynucleotides encoding them
10/15/1998WO1998022588A3 An improved method for the production and purification of adenoviral vectors
10/15/1998WO1998018925A3 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids
10/15/1998WO1998017810A3 Multi-functional chimeric hematopoietic receptor agonists
10/15/1998CA2287778A1 Renal nuclear matrix proteins, polynucleotide sequences encoding them, and their use
10/15/1998CA2287084A1 Diagnosis method and reagents
10/15/1998CA2286860A1 Radioisotope concentrator methods and compositions
10/15/1998CA2286739A1 Improved methods of delivery using cationic lipids and helper lipids
10/15/1998CA2286348A1 Compositions and methods for the treatment and diagnosis of breast cancer
10/15/1998CA2286346A1 Peptides useful for reducing symptoms of toxic shock syndrome
10/15/1998CA2286305A1 Recombinant antibodies specific for beta-amyloid ends, dna encoding and methods of use thereof
10/15/1998CA2286303A1 20 human secreted proteins
10/15/1998CA2285605A1 Fanconi-gene ii
10/15/1998CA2284922A1 Methods for the modulation of the growth of collateral arteries and/or other arteries from preexisting arteriolar connections
10/15/1998CA2232861A1 Cdna clone hacch94 that encodes a novel human 7-transmembrane receptor
10/14/1998EP0870839A1 Method for gene introduction into target cells by retrovirus
10/14/1998EP0870831A1 Histidine kinase polypeptides
10/14/1998EP0870827A2 Tumor necrosis factor related receptor, TR6
10/14/1998EP0870825A1 Human protein kinases hYAK3
10/14/1998EP0870198A1 Recombinant c140 receptor, its agonists and antagonists, and nucleic acids encoding the receptor
10/14/1998EP0870049A2 Complementary adenoviral vector systems and cell lines
10/14/1998EP0870048A1 Host adaptation of retroviral vectors
10/14/1998EP0870041A2 KVLQT1 - A LONG QT SYNDROME GENE WHICH ENCODES KVLQT1 WHICH COASSEMBLES WITH minK TO FORM CARDIAC I Ks? POTASSIUM CHANNELS
10/14/1998EP0870040A2 Gene delivery vehicle-targeting ligands
10/14/1998EP0870036A1 SYNTHETIC MAMMALIAN $g(a)-N-ACETYLGLUCOSAMINIDASE AND GENETIC SEQUENCES ENCODING SAME
10/14/1998EP0870034A1 Novel nagpu
10/14/1998EP0870033A1 Integrin-linked kinase, its inhibitors and methods of medical treatment using these inhibitors, gene therapy and pseudo-substrate inhibitors
10/14/1998EP0870028A1 Nucleic acids encoding interferon gamma inducing factor-2
10/14/1998EP0870027A1 Novel c-mpl receptor agonists
10/14/1998EP0870024A2 Nucleic acid sequences of genes of the high mobility group proteins and uses thereof
10/14/1998EP0870023A1 Osteoprotegerin
10/14/1998EP0870019A2 Cell activation process and reagents therefor
10/14/1998EP0870018A1 Antitumour vector constructs and methods
10/14/1998EP0869972A1 Chemokine from niddm pancreas
10/14/1998EP0869971A1 Two component signal transducing system protein from staphylococcus aureus
10/14/1998EP0869802A1 Vertebrate deltex proteins, nucleic acids, and antibodies, and related methods and compositions
10/14/1998CN1196089A DNA polymerase of gamma herpes viruses associated with kaposi's sarcoma and retroperitoneal fibromatosis
10/13/1998US5821354 Synthesizing a dna sequence in at least two parts; labeling the 5' end of one with a radioisotope; hybridizing; ligating; useful to prevent uncontrolled cellular proliferation
10/13/1998US5821328 Genetic markers for breast, ovarian, and prostatic cancer
10/13/1998US5821235 Gene therapy using the intestine
10/13/1998US5821234 Administering an effective dosage of at least one antisense sequence to at least one gene expressing a cyclin or a cyclin dependent kinase which inhibits the expression of the gene
10/13/1998US5821122 Isolated nucleic acid molecules, peptides which form complexes with MHC molecule HLA-A2 and uses thereof
10/13/1998US5821091 Method of identifying activated T-cells
10/13/1998US5821081 Nucleic acids encoding antiviral proteins and peptides, vectors and host cells comprising same, and methods of producing the antiviral proteins and peptides
10/13/1998US5821071 By introducing a nucleotide sequence encoding a syk gene; gene expression; phosphorylation of fc-gamma receptors; for combatting infections
10/13/1998US5821056 Polynucleotide; expression vector; binding of antibody to a growth differentiation factor-9 polypeptide indicates the presence of an oocyte
10/13/1998US5821046 RNA oligonucleotides that bind HIV tat protein
10/13/1998US5820869 Gene comprising dna sequence encoding the envelope protein
10/13/1998US5820868 Recombinant protein production in bovine adenovirus expression vector system
10/13/1998US5820866 Product and process for T cell regulation
10/10/1998CA2233524A1 Novel compounds
10/08/1998WO1998044143A1 Polymer-modified viruses
10/08/1998WO1998044134A2 Bacterial plasmids
10/08/1998WO1998044132A1 VIRAL VECTORS HAVING CHIMERIC ENVELOPE PROTEINS CONTAINING THE IgG-BINDING DOMAIN OF PROTEIN A
10/08/1998WO1998044131A1 Antimicrobial mediated bacterial dna delivery
10/08/1998WO1998044129A1 Enhancement of immune response using targeting molecules
10/08/1998WO1998044121A1 Modified adenoviral fiber and target adenoviruses
10/08/1998WO1998044118A1 Chemokine beta-6
10/08/1998WO1998044107A1 Diagnosis and prognosis of glaucoma
10/08/1998WO1998044106A1 Transcription factor islet-brain 1 (ib1)
10/08/1998WO1998044103A2 Protein for inhibiting apoptosis
10/08/1998WO1998044102A2 Methods of modulating p33ing1 mediated apoptosis
10/08/1998WO1998044101A1 Antisense oligonucleotides for mitogen-activated protein kinases as therapy for breast cancer
10/08/1998WO1998044096A2 Mycobacterium recombinant vaccines
10/08/1998WO1998043997A1 Novel polypeptide having water channel activity and dna sequence
10/08/1998WO1998043679A1 Human embryonic germ cell line and methods of use
10/08/1998WO1998043669A1 Chimeric viral proteins
10/08/1998WO1998043666A1 Antioxidant protein 2, gene and methods of use therefor
10/08/1998WO1998043482A1 Fibrocyte-based cellular therapy formulations
10/08/1998WO1998043479A1 76 kDa, 32 kDa, AND 50 kDa HELICOBACTER POLYPEPTIDES AND CORRESPONDING POLYNUCLEOTIDE MOLECULES
10/08/1998WO1998043478A1 Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
10/08/1998WO1998032849A3 Polynucleotide associated with the bo or bor syndrome, its corresponding polypeptide and diagnostic and therapeutic applications
10/08/1998WO1998020124A3 Diabetes-mediating proteins and therapeutic uses thereof
10/08/1998WO1998020027A3 Therapeutic use of an agent that stimulates no or prostacyclin production and delivery device
10/08/1998WO1998018930A3 Streptococcus pneumoniae antigens and vaccines
10/08/1998WO1998016646A3 Compounds and methods for immunotherapy and diagnosis of tuberculosis
10/08/1998DE19722317C1 New human ryanodin receptor type 3 polypeptide
10/08/1998DE19713543A1 Bakterielle Plasmide Bacterial plasmids
10/08/1998CA2286893A1 76 kda, 32 kda, and 50 kda helicobacter polypeptides and corresponding polynucleotide molecules
10/08/1998CA2286306A1 Identification of polynucleotides encoding novel helicobacter polypeptides in the helicobacter genome
10/08/1998CA2285692A1 Enhancement of immune response using targeting molecules
10/08/1998CA2285631A1 Antioxidant protein 2, gene and methods of use therefor
10/08/1998CA2285622A1 Chemokine beta-6
10/08/1998CA2285565A1 Modified adenoviral fiber and target adenoviruses
10/08/1998CA2285416A1 Polymer-modified viruses
10/08/1998CA2285274A1 Human embryonic germ cell line and methods of use
10/08/1998CA2284736A1 Mycobacterium recombinant vaccines
10/08/1998CA2284730A1 Methods of modulating p33ing1 mediated apoptosis
10/08/1998CA2284471A1 Fibrocyte-based cellular therapy formulations
10/08/1998CA2281903A1 Antisense oligonucleotides for mitogen-activated protein kinases as therapy for breast cancer
10/08/1998CA2227932A1 Gene encoding invasion protein of campylobacter jejuni
10/07/1998EP0869180A1 A TNF homologue, TL5
1 ... 780 781 782 783 784 785 786 787 788 789 790 791 792 793 794 795 796 797 798 799 800 ... 870